Based on forecasted data, the sales of Alimentary Tract and Metabolism Medicines in Sweden from 2024 to 2028 are as follows (in Million US Dollars PPP):
- 2024: 909.1
- 2025: 974.5
- 2026: 1040.0
- 2027: 1100.0
- 2028: 1170.0
Year-on-Year Variation:
- 2024-2025: 7.2%
- 2025-2026: 6.7%
- 2026-2027: 5.8%
- 2027-2028: 6.4%
The Compound Annual Growth Rate (CAGR) for the period 2024-2028 is projected to be approximately 6.13%, indicating a steady upward trend.
Future Trends to Watch: Factors such as demographic changes, increasing prevalence of chronic diseases, advancements in medical technologies, and potential policy changes in healthcare expenditure will potentially influence the sales trajectory of Alimentary Tract and Metabolism Medicines in Sweden.
